FDA Inspection 823228 — Milos Gregus
The FDA completed an inspection of Milos Gregus on Feb 8, 2013 in Nitra. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 8, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nitra (Slovakia)
Additional details
Clinical Investigator (CI)